Top

Orphanet Journal of Rare Diseases

Published in:

Open Access 01-12-2020 | Sphingolipidosis | Research

Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities

Authors: G. Hazan, E. Hershkovitz, O. Staretz-Chacham

Published in: Orphanet Journal of Rare Diseases | Issue 1/2020

Abstract

Background

Inherited metabolic disorders (IMDs) are group of rare monogenic diseases, usually derived from reduced or absent activity in a single metabolic pathway. Most of the IMDs are inherited in an autosomal recessive manner. The incidence of IMDs varies from country to country and within different ethnic groups, but data is still scarce. Consanguinity rate among populations is highly contributor factor for IMDs incidence. There are no reports comparing the incidence of IMD in consanguineous and non-consanguineous populations from the same geographic region with the same diagnostic capabilities. Our study objective is to compare the incidence of IMDs between between the relatively low consanguineous Jewish population and the consanguineous Bedouin population, both living in the southern of Israel.

Results

During 1990–2017 there were 393,772 live births in the Negev district, of Southern of Israel. Among them 187,049 were of Jewish origin while 206,723 were of Bedouin-Muslim origin. A total of 223 children were diagnosed in this study period with IMDs. Among those 223 children with IMD, 33 were of Jewish origin while the other 190 children were of Bedouin-Muslim origin. The overall incidence for IMDs of the overall Negev population was 56.6/100,000 live birth. The incidence for IMD's among the Bedouin population was significantly higher than among Jewish population.

Conclusions

IMDs are extremely more common in the consanguineous Bedouin compared with the relatively non-consanguineous Jewish population of Southern Israel. Health policy makers should consider these data and prepare educational and genetic counselling problems accordingly.

Scriver CR, Beaudet AL, Sly WS, et al. The metabolic and molecular bases of inherited diseases, vol. 1. New York: McGraw-Hill; 2001. p. 53–118.

Tebani A, Abily-Donval L, Afonso C, Marret S, Bekri S. Clinical metabolomics: the new metabolic window for inborn errors of metabolism investigations in the post-genomic era. Int J Mol Sci. 2016. https://doi.org/10.3390/ijms17071167. CrossRefPubMedPubMedCentral

Afzal RM, Lund AM, Skovby F. The impact of consanguinity on the frequency of inborn errors of metabolism. Mol Genet Metab Rep. 2018;15:6–10. https://doi.org/10.1016/j.ymgmr.2017.11.004. CrossRefPubMedPubMedCentral

Jimenez-Sanchez G, Childs B, Valle D. Human disease genes. Nature. 2001;409:853–5. CrossRef

Martins AM. Inborn errors of metabolism: a clinical overview. Sao Paulo Med J. 1999;117(6):251–65. CrossRef

Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, Littlejohns P, Lord J, Wilcox AH. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess. 1997;1(11):1–95. CrossRef

Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348(2304–12):5.

Dionisi-Vici C, Rizzo C, Burlina AB, Caruso U, Sabetta G, Uziel G, et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr. 2002;140:321–7. CrossRef

Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands. UK Arch Dis Child. 2006;91:896–9. CrossRef

10.

Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics. 2000;105:e10. CrossRef

11.

Wilcken B, Wiley V, Hammond J, et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. New Engl J Med. 2003;348(2304–12):9.

12.

Venditti LN, Venditti CP, Berry GT, et al. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a costeffectiveness analysis. Pediatrics. 2003;112:1005–15. CrossRef

13.

Pandor A, Eastham J, Beverley C, et al. Clinical effectiveness and costeffectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technol Assess. 2004;8:1–121. CrossRef

14.

Muller E, Kolker S. Reduction of lysine intake while avoiding malnutrition—major goals and major problems in dietary treatment of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27:903–10. CrossRef

15.

Miebach E. Enzyme replacement therapy in mucopolysaccharidosis type I. Acta Paediatr Suppl. 2005;94:58–60. CrossRef

16.

Mignani R, Cagnoli L. Enzyme replacement therapy in Fabry’s disorder: recent advances and clinical applications. J Nephrol. 2004;17:354–63. PubMed

17.

Eto Y, Shen JS, Meng XL, et al. Treatment of lysosomal storage disorders: cell therapy and gene therapy. J Inherit Metab Dis. 2004;27:411–5. CrossRef

18.

Sauer M, Grewal S, Peters C. Hematopoietic stem cell transplantation for mucopolysaccharidoses and leukodystrophies. Klin Padiatr. 2004;216:163–8. CrossRef

19.

Broides A, Nahum A, Mandola AB, Rozner L, Pinsk V, Ling G, Yerushalmi B, Levy J, Givon-Lavi N. Incidence of typically severe primary immunodeficiency diseases in consanguineous and non-consanguineous populations. J Clin Immunol. 2017;37(3):295–300. https://doi.org/10.1007/s10875-017-0378-6. CrossRefPubMed

20.

El-Hazmi MA, Warsy A. Genetic disorders among Arab populations. Saudi Med J. 1996;17:108–23.

21.

El-Hazmi MA, al-Swailem AR, Warsy AS, al-Swailem AM, Sulaimani R, al-Meshari AA. Consanguinity among the Saudi Arabian population. J Med Genet. 1995;32:623–6. CrossRef

22.

Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ. 2006;333:831–4. CrossRef

23.

Moammar H, Cheriyan G, Mathew R, Al-Sannaa N. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983–2008. Ann Saudi Med. 2010;30(4):271–7. https://doi.org/10.4103/0256-4947.65254. CrossRefPubMedPubMedCentral

24.

Al-Saud B, Al-Mousa H, Al Gazlan S, Al-Ghonaium A, Arnaout R, Al-Seraihy A. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35:651–60. CrossRef

25.

Na’amnih W, Romano-Zelekha O, Kabaha A, Rubin LP, Bilenko N, Jaber L, et al. Prevalence of consanguineous marriages and associated factors among Israeli Bedouins. J Community Genet. 2014;5:395–8. CrossRef

26.

Central Bureau of Statistics Israel. Statistical abstract of Israel. https://www.cbs.gov.il/shnaton64/st02_19x.pdf. Accessed June 2018.

27.

Abu-Ghanem S, Sheiner E, Sherf M, Wiznitzer A, Sergienko R, Shoham-Vardi I. Lack of prenatal care in a traditional community: trends and perinatal outcomes. Arch Gynecol Obstet. 2012;285(5):1237–42. https://doi.org/10.1007/s00404-011-2153-x. CrossRefPubMed

28.

Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R. Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol. 1998;76(2):141–6. CrossRef

29.

https://www.health.gov.il/hozer/mr02_2018.pdf. (HEB)

30.

Parvari R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT. A single-base deletion in the 3’-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. Eur J Hum Genet. 1997;5(5):266–70. CrossRef

31.

Parvari R, Moses S, Hershkovitz E, Carmi R, Bashan N. Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab. J Inherit Metab Dis. 1995;18(1):21–7. https://doi.org/10.1007/BF00711368. CrossRefPubMed

32.

Cohen T, Vardi-Saliternik R, Friedlander Y. Consanguinity, intracommunity and intercommunity marriages in a population sample of Israeli Jews. Ann Hum Biol. 2004;31(1):38–48. https://doi.org/10.1080/0301446032000159255. CrossRefPubMed

33.

Zlotogora J. Autosomal recessive diseases among the Israeli Arabs. Hum Genet. 2019;138(10):1117–22. https://doi.org/10.1007/s00439-019-02043-3. CrossRefPubMed

34.

Raz AE, Atar M. Cousin marriage and premarital carrier matching in a Bedouin community in Israel: attitudes, service development and educational intervention. J Fam Plann Reprod Health Care. 2004;30(1):49–51. https://doi.org/10.1783/147118904322701992. CrossRefPubMed

35.

https://www.cbs.gov.il/EN/pages/default.aspx—Central Bureau of Statistics Report 2006.

36.

Therrell BL Jr, Lloyd-Puryear MA, Camp KM, Mann MY. Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning. Mol Genet Metab. 2014;113(1–2):14–26. CrossRef

Title: Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities
Authors: G. Hazan
E. Hershkovitz
O. Staretz-Chacham
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Sphingolipidosis
Sphingolipidosis
Neonatal Screening
Published in: Orphanet Journal of Rare Diseases / Issue 1/2020
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-020-01578-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

A novel prognostic model for adult patients with Hemophagocytic Lymphohistiocytosis

The modified Atkins diet in children with Prader-Willi syndrome

Non-deletional alpha thalassaemia: a review

Correction to: Medical expenditure for patients with hemophilia in urban China: data from medical insurance information system from 2013 to 2015

Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential

Nationwide carrier detection and molecular characterization of β-thalassemia and hemoglobin E variants in Bangladeshi population